Literature DB >> 22926418

Regulation of mu opioid receptor expression in developing T cells.

Lily Zhang1, Judith Sliker Belkowski, Tammi Briscoe, Thomas J Rogers.   

Abstract

We have previously reported that functionally active μ-opioid receptors (MOR) are constitutively expressed at relatively low levels by developing T cells in the thymus. However, very little is known about the regulation of MOR expression by immature T cells. In this report, we first attempted to determine the effect of T cell receptor-induced T cell activation on the expression of MOR. We activated T cells with either the combination of anti-CD3 and CD28, or with superantigen, and observed a substantial increase in MOR transcript expression. We also chose to examine the effect of cytokine-mediated T cell activation on the expression of this opioid receptor. We selected certain cytokines that play a role in T cell development and are known to be present at functional levels in the thymus gland. Our results show that interferon γ (IFNγ), IL-1β, and IL-2, and in particular transforming growth factor-β (TGFβ), all induced significant increases in MOR transcript expression. On the other hand, both TNFα and IL-7 exhibited much weaker effects on MOR expression. These results show that MOR expression by developing T cells is strongly regulated by several cytokines involved in T cell development in the thymus gland.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22926418      PMCID: PMC3518723          DOI: 10.1007/s11481-012-9396-6

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  62 in total

1.  Expression of functional mu-opioid receptors during T cell development.

Authors:  L McCarthy; I Szabo; J F Nitsche; J E Pintar; T J Rogers
Journal:  J Neuroimmunol       Date:  2001-03-01       Impact factor: 3.478

Review 2.  Thymic and intestinal intraepithelial T lymphocyte development are each regulated by the gammac-dependent cytokines IL-2, IL-7, and IL-15.

Authors:  B O Porter; T R Malek
Journal:  Semin Immunol       Date:  2000-10       Impact factor: 11.130

3.  A requirement for IL-2/IL-2 receptor signaling in intrathymic negative selection.

Authors:  H Bassiri; S R Carding
Journal:  J Immunol       Date:  2001-05-15       Impact factor: 5.422

Review 4.  Opioid G protein-coupled receptors: signals at the crossroads of inflammation.

Authors:  Thomas J Rogers; Phillip K Peterson
Journal:  Trends Immunol       Date:  2003-03       Impact factor: 16.687

Review 5.  Cytokines in the thymus: production and biological effects.

Authors:  Alexandr A Yarilin; Igor M Belyakov
Journal:  Curr Med Chem       Date:  2004-02       Impact factor: 4.530

6.  Mu and delta receptors mediate morphine effects on phagocytosis by murine peritoneal macrophages.

Authors:  Nilka Tomassini; Fernando L Renaud; Sabita Roy; Horace H Loh
Journal:  J Neuroimmunol       Date:  2003-03       Impact factor: 3.478

7.  Methionine-enkephalin-and Dynorphin A-release from immune cells and control of inflammatory pain.

Authors:  P J Cabot; L Carter; M Schäfer; C Stein
Journal:  Pain       Date:  2001-09       Impact factor: 6.961

8.  Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain.

Authors:  Shaaban A Mousa; Halina Machelska; Michael Schäfer; Christoph Stein
Journal:  J Neuroimmunol       Date:  2002-05       Impact factor: 3.478

9.  TNF and Fas-induced apoptosis during negative selection in thymic nurse cells.

Authors:  M Pezzano; M Samms; J C Guyden
Journal:  Ethn Dis       Date:  2001       Impact factor: 1.847

10.  The delta-opioid receptor participates in T-cell development by promoting negative selection.

Authors:  Lois E McCarthy; Joshua F Nitsche; John E Pintar; Thomas J Rogers
Journal:  J Neuroimmunol       Date:  2004-08       Impact factor: 3.478

View more
  8 in total

1.  The molecular basis for neuroimmune receptor signaling.

Authors:  Thomas J Rogers
Journal:  J Neuroimmune Pharmacol       Date:  2012-08-31       Impact factor: 4.147

2.  µ-opioid receptor, β-endorphin, and cannabinoid receptor-2 are increased in the colonic mucosa of irritable bowel syndrome patients.

Authors:  Giovanni Dothel; Lin Chang; Wendy Shih; Maria Raffaella Barbaro; Cesare Cremon; Vincenzo Stanghellini; Fabrizio De Ponti; Emeran A Mayer; Giovanni Barbara; Catia Sternini
Journal:  Neurogastroenterol Motil       Date:  2019-07-23       Impact factor: 3.598

3.  The synthetic opioid fentanyl increases HIV replication and chemokine co-receptor expression in vitro.

Authors:  Ling Kong; Mohamed Tarek M Shata; Jennifer L Brown; Michael S Lyons; Kenneth E Sherman; Jason T Blackard
Journal:  J Neurovirol       Date:  2022-08-17       Impact factor: 3.739

4.  Electroacupuncture Attenuates Surgical Stress-Induced Reduction of T Lymphocytes through Modulation of Peripheral Opioid System.

Authors:  Ke Wang; Yue Yong; Jia Zhou; Wen-Xiong Zhou; Jun Guo; Tong-Yu Chen
Journal:  Chin J Integr Med       Date:  2020-09-26       Impact factor: 1.978

5.  Morphine Suppresses T helper Lymphocyte Differentiation to Th1 Type Through PI3K/AKT Pathway.

Authors:  Mao Mao; Yanning Qian; Jie Sun
Journal:  Inflammation       Date:  2016-04       Impact factor: 4.092

6.  The synthetic opioid fentanyl enhances viral replication in vitro.

Authors:  Ling Kong; Rebekah Karns; Mohamed Tarek M Shata; Jennifer L Brown; Michael S Lyons; Kenneth E Sherman; Jason T Blackard
Journal:  PLoS One       Date:  2021-04-14       Impact factor: 3.752

Review 7.  Expression of Opioid Receptors in Cells of the Immune System.

Authors:  Jana Brejchova; Vladimir Holan; Petr Svoboda
Journal:  Int J Mol Sci       Date:  2020-12-30       Impact factor: 5.923

8.  Nitric oxide and histone deacetylases modulate cocaine-induced mu-opioid receptor levels in PC12 cells.

Authors:  Warren Winick-Ng; Francesco Leri; Bettina E Kalisch
Journal:  BMC Pharmacol Toxicol       Date:  2012-10-18       Impact factor: 2.483

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.